GN Store Nord A/S (GN.CO)
107.00 DKK +0.71%
GN Store Nord A/S rose 0.71% in the latest session, at 107.00 DKK. By market cap it is number 8 of the 9 health care stocks on the C25 heatmap. The price is 13.5% below its 52-week high.
Key numbers
- Price
- 107.00 DKK
- Day change
- +0.71% (0.75)
- Market cap
- 15.6B DKK
- P/E (trailing)
- —
- P/E (forward)
- 21.7
- Dividend yield
- —
- 50-day average
- 103.21
- 200-day average
- 98.03
- 52-week range
- 85.12 – 123.75
- Next earnings
- 5 Nov 2026
Data as of 3 Nov 2026, 16:59 CET. Market data may be delayed.
GN Store Nord A/S over the past year
From daily closing prices. The highest close in the period was 118.20 DKK on 13 Jan 2026, the lowest 86.50 DKK on 29 Jun 2026.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +1.52% | +8.98% | +8.06% | +0.23% | -0.05% |
| Month | Close (DKK) | Change |
|---|---|---|
| November 2026 | 107.00 | +0.23% |
| October 2026 | 106.75 | -3.61% |
| September 2026 | 110.75 | +14.58% |
| August 2026 | 96.66 | -1.06% |
| July 2026 | 97.70 | +11.96% |
| June 2026 | 87.26 | -11.19% |
| May 2026 | 98.26 | +2.63% |
| April 2026 | 95.74 | -5.07% |
| March 2026 | 100.85 | +7.70% |
| February 2026 | 93.64 | -15.68% |
| January 2026 | 111.05 | +4.03% |
| December 2025 | 106.75 | +3.09% |
Health care peers
GN Store Nord A/S is on the C25 heatmap (Health care). How it compares with the other health care stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Novo Nordisk A/S NOVO-B.CO | -0.02% | 1.19T DKK | 10.3 |
| Genmab A/S GMAB.CO | +0.57% | 229B DKK | 45.9 |
| Coloplast A/S COLO-B.CO | +2.97% | 112B DKK | 36.3 |
| Demant A/S DEMANT.CO | -0.97% | 77.1B DKK | 31.9 |
| ALK-Abelló A/S ALK-B.CO | +0.65% | 54.7B DKK | 40.5 |
| Ambu A/S AMBU-B.CO | +0.86% | 21.5B DKK | 42.9 |
| Bavarian Nordic A/S BAVA.CO | -2.71% | 18.2B DKK | 12.5 |
| GN Store Nord A/S GN.CO | +0.71% | 15.6B DKK | — |
| Zealand Pharma A/S ZEAL.CO | +1.17% | 15.5B DKK | 6.1 |
More on GN
Open GN.CO in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.